Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species
Human Kallikrein 10 ELISA Kit for Competition ELISA - ABIN415167
Ari, Ozturk, Bez, Oktar, Erduran: High plasma nesfatin-1 level in patients with major depressive disorder. in Progress in neuro-psychopharmacology & biological psychiatry 2011
Show all 13 references for 415167
Data suggest that mature KLK9 (kallikrein 9 (show KLK9 ELISA Kits)) is a glycosylated chymotrypsin-like enzyme with strong preference for tyrosine over phenylalanine at P1 cleavage position; substrate specificity of KLK9 (show KLK9 ELISA Kits) appears to extend to KLK10 and midkine (show MDK ELISA Kits); enzyme activity is enhanced by Mg2 (show MUC7 ELISA Kits)+ and Ca2 (show CA2 ELISA Kits)+, but is reversibly attenuated by Zn2+; KLK9 (show KLK9 ELISA Kits) is inhibited in vitro by many naturally occurring or synthetic protease inhibitors.
KLK10 potentially plays a crucial role in esophageal cancer cell growth.
KLK10 may function as a tumour suppressor by repressing proliferation, enhancing apoptosis and decreasing glucose metabolism in PC3 (show PCSK1 ELISA Kits) cells.
treated and untreated prolactin (show PRL ELISA Kits)-producing pituitary adenomas and carcinomas as well as TSH-producing pituitary adenomas and carcinomas were conclusively immunopositive for KLK10
Immunoexpression of KLK10 in the ACTH (show POMC ELISA Kits)-secreting tumors as well as in the Crooke cell tumors was significantly increased when compared with the nonfunctioning tumors and in the corticotrophs of non-tumorous pituitaries.
Data indicate that elevated expression of microRNA-375 in head and neck squamous cell carcinoma (HNSCC) cells significantly reduces kallikrein 6 (KLK6 (show KLK6 ELISA Kits)), kallikrein 10 (KLK10), and matrix metalloproteinase 9 (MMP9 (show MMP9 ELISA Kits)) messenger RNA expression.
is the first correlation of oral squamous cell carcinoma with KLK10 rs3745535G>T polymorphisms
KLK6 (show KLK1 ELISA Kits) and KLK10 may be useful markers and potential therapeutic targets in gastroesophageal junction tumors
This study assessed the prognostic utility of human tissue kallikrein (show KLK1 ELISA Kits)-like peptidases 6 and 10 (KLK6 (show KLK1 ELISA Kits) and KLK10) and correlated their expression with histopathological and clinical parameters in gastric cancer.
KLK10 expression is an independent biomarker of unfavorable prognosis in patients with gastric cancer.
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Its encoded protein is secreted and may play a role in suppression of tumorigenesis in breast and prostate cancers. Alternate splicing of this gene results in multiple transcript variants encoding the same protein.
kallikrein-related peptidase 10
, kallikrein 10
, breast normal epithelial cell associated serine protease
, normal epithelial cell-specific 1
, protease serine-like 1
, protease, serine-like, 1